Immunophotonics, Inc. logo

Immunophotonics, Inc.

Interventional Immuno-Oncology

17 employees · est. 2012 · St. Louis, United States

VS
IO Biotech logo

IO Biotech

Break Boundaries. Ignite Change.

91 employees · est. 2015 · Denmark

Immunophotonics, Inc. is the older company (2012 vs 2015); IO Biotech is the larger of the two.

Side-by-Side Comparison

Immunophotonics, Inc. IO Biotech
Founded
2012 older 2015
Headquarters
St. Louis, United States Denmark
Employees
17 91 larger
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Health Care, Health and Wellness
Funding Stage
Series Unknown Post Ipo Equity
Total Funding
$31.87M $198.00M
Funding Rounds
10 5
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Not tracked yet Biopharmaceutical, Clinical-stage, Immune-modulating, Cancer Vaccine, Combination Therapy, TME, T-win® Vaccine Platform, Phase 3 Development, Copenhagen, Immuno-oncology, Management Team, Advisory Board
Website
immunophotonics.com iobiotech.com
Immunophotonics, Inc. logo

About Immunophotonics, Inc.

Immunophotonics is a privately owned clinical stage biotech that has discovered a novel and simple approach to achieve patient-specific anticancer immunity. The company is currently developing its first asset, the immune-modulating proprietary carbohydrate polymer IP-001 for the treatment of solid t...

IO Biotech logo

About IO Biotech

IO Biotech is a clinical-stage biopharmaceutical company headquartered in Copenhagen, Denmark. The company's mission revolves around pioneering a first-in-class investigational dual-action immune-modulating cancer vaccine, with the ultimate goal of serving as the backbone of combination therapy for...

We will tell you when either one moves

BounceWatch watches Immunophotonics, Inc. and IO Biotech for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Immunophotonics, Inc. and IO Biotech — by email.

Frequently Asked Questions

Immunophotonics, Inc. — Interventional Immuno-Oncology. IO Biotech — Break Boundaries. Ignite Change.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Immunophotonics, Inc. has raised $31.87M while IO Biotech has raised $198.00M.
Immunophotonics, Inc. and IO Biotech operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Immunophotonics, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Immunophotonics, Inc. on 13 Sep 2024, and IO Biotech on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy